![[ Visit Client Website ]](images/banner.gif)
Monday, June 23, 2008
Petree C (LA Convention Center)
Abstract Pain Management Post Cesarean Section
Optimal management of pain is imperative for successful recovery of the postoperative cesarean section patient. Current available research demonstrates that drug combinations are critical in achieving effective pain control with minimal side effects. In an effort to continuously improve the quality of care provided to patients in our facility, there is interest in investigating the use of combination drugs in the postoperative caesarean section patient. The purpose of this study will be to determine whether post cesarean section pain management is most effective using combination oral Percocet and intravenous Toradol compared to PCA delivery of Morphine or Demerol with intravenous Toradol use This research study is designed to address whether Percocet and Toradol show a significant difference in pain management in the post cesarean section patient by measuring pain, length of stay, and quality of post-operative experience as determined by a patient rating scale and questionnaire. All subjects will have a six-week follow up visit at Women’s Health Advantage’s office. A functional criteria form including an opportunity to rate quality of pain in a narrative form will be completed during this visit.
The sample will be a study of 200 Women’s Health Advantage (WHA) female patients greater than 36 weeks gestation presenting for scheduled, primary, or repeat cesarean section delivery. The patient will be randomly assigned to one of two study group arms: 100 participants in the Toradol and Percocet arm and 100 participants in the Toradol and PCA with either Demerol or Morphine arm. Inclusion criteria will be: Women’s Health Advantage patients, age 18-42 years, scheduled primary or repeat cesarean section, with cognitive ability to rate pain. Exclusion criteria will be: patients outside of Women’s Health Advantage, unscheduled or emergency caesarean section, and/or use of spinal anesthetic or Duramorph use. Informed consent will be obtained from all participating subjects, after verbal and written information is provided to all participants. This study utilizes a comparative descriptive design that will examine and describe the differences in the variables of the two study groups. It is imperative that all nurses participate in meaningful unit-specific research projects designed to answer questions related to improving patient outcomes, quality of care, and best practice protocols.
Optimal management of pain is imperative for successful recovery of the postoperative cesarean section patient. Current available research demonstrates that drug combinations are critical in achieving effective pain control with minimal side effects. In an effort to continuously improve the quality of care provided to patients in our facility, there is interest in investigating the use of combination drugs in the postoperative caesarean section patient. The purpose of this study will be to determine whether post cesarean section pain management is most effective using combination oral Percocet and intravenous Toradol compared to PCA delivery of Morphine or Demerol with intravenous Toradol use This research study is designed to address whether Percocet and Toradol show a significant difference in pain management in the post cesarean section patient by measuring pain, length of stay, and quality of post-operative experience as determined by a patient rating scale and questionnaire. All subjects will have a six-week follow up visit at Women’s Health Advantage’s office. A functional criteria form including an opportunity to rate quality of pain in a narrative form will be completed during this visit.
The sample will be a study of 200 Women’s Health Advantage (WHA) female patients greater than 36 weeks gestation presenting for scheduled, primary, or repeat cesarean section delivery. The patient will be randomly assigned to one of two study group arms: 100 participants in the Toradol and Percocet arm and 100 participants in the Toradol and PCA with either Demerol or Morphine arm. Inclusion criteria will be: Women’s Health Advantage patients, age 18-42 years, scheduled primary or repeat cesarean section, with cognitive ability to rate pain. Exclusion criteria will be: patients outside of Women’s Health Advantage, unscheduled or emergency caesarean section, and/or use of spinal anesthetic or Duramorph use. Informed consent will be obtained from all participating subjects, after verbal and written information is provided to all participants. This study utilizes a comparative descriptive design that will examine and describe the differences in the variables of the two study groups. It is imperative that all nurses participate in meaningful unit-specific research projects designed to answer questions related to improving patient outcomes, quality of care, and best practice protocols.
See more of: Research Posters